IBDEI0GN ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,513,0)
 ;;=ENDOCRINE/METABOLIC^5^62
 ;;^UTILITY(U,$J,358.4,514,0)
 ;;=PULMONARY^19^62
 ;;^UTILITY(U,$J,358.4,515,0)
 ;;=EENT^4^62
 ;;^UTILITY(U,$J,358.4,516,0)
 ;;=MUSCULOSKELETAL^13^62
 ;;^UTILITY(U,$J,358.4,517,0)
 ;;=NEURO^14^62
 ;;^UTILITY(U,$J,358.4,518,0)
 ;;=MENTAL HEALTH^12^62
 ;;^UTILITY(U,$J,358.4,519,0)
 ;;=GASTROENTEROLOGY^6^62
 ;;^UTILITY(U,$J,358.4,520,0)
 ;;=GU / RENAL^7^62
 ;;^UTILITY(U,$J,358.4,521,0)
 ;;=WOMEN'S HEALTH^22^62
 ;;^UTILITY(U,$J,358.4,522,0)
 ;;=HEMATOLOGY/ONCOLOGY^8^62
 ;;^UTILITY(U,$J,358.4,523,0)
 ;;=INFECTIOUS DISEASE^10^62
 ;;^UTILITY(U,$J,358.4,524,0)
 ;;=DERMATOLOGY^3^62
 ;;^UTILITY(U,$J,358.4,525,0)
 ;;=HISTORY OF ILLNESS^9^62
 ;;^UTILITY(U,$J,358.4,526,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^17^62
 ;;^UTILITY(U,$J,358.4,527,0)
 ;;=INJURY/TRAUMA^11^62
 ;;^UTILITY(U,$J,358.4,528,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^21^62
 ;;^UTILITY(U,$J,358.4,529,0)
 ;;=SEXUAL TRAUMA^20^62
 ;;^UTILITY(U,$J,358.4,530,0)
 ;;=PAIN^16^62
 ;;^UTILITY(U,$J,358.4,531,0)
 ;;=OTHER REASONS^15^62
 ;;^UTILITY(U,$J,358.4,532,0)
 ;;=COMMON DIAGNOSES^1^62
 ;;^UTILITY(U,$J,358.4,533,0)
 ;;=PREVENTIVE MEDICINE CODES^18^62
 ;;^UTILITY(U,$J,358.4,534,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^.5^62
 ;;^UTILITY(U,$J,358.4,535,0)
 ;;=ORTHOTIC DEVICES^2^63
 ;;^UTILITY(U,$J,358.4,536,0)
 ;;=THERAPY EVALUATIONS^3^63
 ;;^UTILITY(U,$J,358.4,537,0)
 ;;=HOME THERAPY SERVICES^1^63
 ;;^UTILITY(U,$J,358.4,538,0)
 ;;=FUNCTIONAL RPTING BODY POSITION^4^63
 ;;^UTILITY(U,$J,358.4,539,0)
 ;;=FUNCTIONAL RPTING CARRY OBJECTS^5^63
 ;;^UTILITY(U,$J,358.4,540,0)
 ;;=FUNCTIONAL RPTING MOBILITY^6^63
 ;;^UTILITY(U,$J,358.4,541,0)
 ;;=FUNCTIONAL RPTING OTH PT/OT PRI^7^63
 ;;^UTILITY(U,$J,358.4,542,0)
 ;;=FUNCTIONAL RPTING OTH PT/OT SUB^8^63
 ;;^UTILITY(U,$J,358.4,543,0)
 ;;=FUNCTIONAL RPTING SELF CARE^9^63
 ;;^UTILITY(U,$J,358.4,544,0)
 ;;=PRIMARY DIAGNOSES^1^64
 ;;^UTILITY(U,$J,358.4,545,0)
 ;;=V CODES ^1^65
 ;;^UTILITY(U,$J,358.4,546,0)
 ;;=AMPUTATION STATUS^2^65
 ;;^UTILITY(U,$J,358.4,547,0)
 ;;=BRAIN DISORDERS^3^65
 ;;^UTILITY(U,$J,358.4,548,0)
 ;;=CARDIOPULMONARY^4^65
 ;;^UTILITY(U,$J,358.4,549,0)
 ;;=COMPLICATION DUE TO^5^65
 ;;^UTILITY(U,$J,358.4,550,0)
 ;;=FRACTURES-LATE EFFECTS^6^65
 ;;^UTILITY(U,$J,358.4,551,0)
 ;;=MENTAL DISORDERS^7^65
 ;;^UTILITY(U,$J,358.4,552,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^8^65
 ;;^UTILITY(U,$J,358.4,553,0)
 ;;=TERTIARY DX-TBI CODES^10^65
 ;;^UTILITY(U,$J,358.4,554,0)
 ;;=QUATERNARY DX-POLYTRAUMA/TBI V-CODE^9^65
 ;;^UTILITY(U,$J,358.4,555,0)
 ;;=ADJUSTMENT DISORDERS^1^66
 ;;^UTILITY(U,$J,358.4,556,0)
 ;;=ANXIETY DISORDERS^3^66
 ;;^UTILITY(U,$J,358.4,557,0)
 ;;=AMNESTICS^2^66
 ;;^UTILITY(U,$J,358.4,558,0)
 ;;=ORGANIC DISORDERS^9^66
 ;;^UTILITY(U,$J,358.4,559,0)
 ;;=DEMENTIA^5^66
 ;;^UTILITY(U,$J,358.4,560,0)
 ;;=DELIRIUM^4^66
 ;;^UTILITY(U,$J,358.4,561,0)
 ;;=BIPOLAR DISORDERS^3.5^66
 ;;^UTILITY(U,$J,358.4,562,0)
 ;;=PSYCHOSIS/OTHER^12^66
 ;;^UTILITY(U,$J,358.4,563,0)
 ;;=PERSONALITY DISORDERS^11^66
 ;;^UTILITY(U,$J,358.4,564,0)
 ;;=SEXUAL DISORDERS^14^66
 ;;^UTILITY(U,$J,358.4,565,0)
 ;;=SLEEP DISORDERS^15^66
 ;;^UTILITY(U,$J,358.4,566,0)
 ;;=OTHER DISORDERS^18^66
 ;;^UTILITY(U,$J,358.4,567,0)
 ;;=SUBSTANCE RELATED DISORDERS^19^66
 ;;^UTILITY(U,$J,358.4,568,0)
 ;;=V CODES^17^66
 ;;^UTILITY(U,$J,358.4,569,0)
 ;;=PREVENTION/COUNSELING/SCREEN^21^66
 ;;^UTILITY(U,$J,358.4,570,0)
 ;;=DEPRESSION^6^66
 ;;^UTILITY(U,$J,358.4,571,0)
 ;;=MOOD DISORDERS (OTHER)^8^66
 ;;^UTILITY(U,$J,358.4,572,0)
 ;;=SCHIZOPHRENIA^13^66
 ;;^UTILITY(U,$J,358.4,573,0)
 ;;=SOMATIFORM DISORDERS^16^66
 ;;^UTILITY(U,$J,358.4,574,0)
 ;;=EATING DISORDERS^7^66
 ;;^UTILITY(U,$J,358.4,575,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^10^66
 ;;^UTILITY(U,$J,358.4,576,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^.5^66
 ;;^UTILITY(U,$J,358.4,577,0)
 ;;=PSYCHOTHERAPY (INPT OR OUTPT)^2^67
 ;;^UTILITY(U,$J,358.4,578,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^3^67
 ;;^UTILITY(U,$J,358.4,579,0)
 ;;=OTHER CODES^6^67
 ;;^UTILITY(U,$J,358.4,580,0)
 ;;=BEHAVIOR ASSESSMENT/INTERVENTION^4^67
 ;;^UTILITY(U,$J,358.4,581,0)
 ;;=TEAM CONFERENCE^8^67
 ;;^UTILITY(U,$J,358.4,582,0)
 ;;=INTERACTIVE COMPLEXITY^5^67
 ;;^UTILITY(U,$J,358.4,583,0)
 ;;=SUBSTANCE ABUSE^7^67
 ;;^UTILITY(U,$J,358.4,584,0)
 ;;=PSYCHIATRIC DIAGNOSTIC EVALUATION^1^67
 ;;^UTILITY(U,$J,358.4,585,0)
 ;;=ANEMIA^1^68
 ;;^UTILITY(U,$J,358.4,586,0)
 ;;=COAGULATION DISORDERS^4^68
 ;;^UTILITY(U,$J,358.4,587,0)
 ;;=MYELOID NEOPLASMS & DISORDERS^13^68
 ;;^UTILITY(U,$J,358.4,588,0)
 ;;=LYMPHOID NEOPLASMS^10^68
 ;;^UTILITY(U,$J,358.4,589,0)
 ;;=GI CANCER^7^68
 ;;^UTILITY(U,$J,358.4,590,0)
 ;;=HEAD, NECK & LUNG NEOPLASMS^8^68
 ;;^UTILITY(U,$J,358.4,591,0)
 ;;=MISC. NEOPLASMS^12^68
 ;;^UTILITY(U,$J,358.4,592,0)
 ;;=METASTATIC SITES^11^68
 ;;^UTILITY(U,$J,358.4,593,0)
 ;;=COUNSELING & SCREENING^5^68
 ;;^UTILITY(U,$J,358.4,594,0)
 ;;=HEMOGLOBINOPATHIES^9^68
 ;;^UTILITY(U,$J,358.4,595,0)
 ;;=GENITOURINARY NEOPLASMS^6^68
 ;;^UTILITY(U,$J,358.4,596,0)
 ;;=BREAST & GYN NEOPLASMS^3^68
 ;;^UTILITY(U,$J,358.4,597,0)
 ;;=ARTIFICIAL OPENING STATUS^2^68
 ;;^UTILITY(U,$J,358.4,598,0)
 ;;=PERSONAL HX OF CANCER^14^68
 ;;^UTILITY(U,$J,358.4,599,0)
 ;;=SPECIAL SERVICES^5^69
 ;;^UTILITY(U,$J,358.4,600,0)
 ;;=TREATMENT^4^69
 ;;^UTILITY(U,$J,358.4,601,0)
 ;;=MISCELLANEOUS^7^69
 ;;^UTILITY(U,$J,358.4,602,0)
 ;;=IMMUNIZATIONS^6^69
 ;;^UTILITY(U,$J,358.4,603,0)
 ;;=CHEMO ADMINISTRATION^1^69
 ;;^UTILITY(U,$J,358.4,604,0)
 ;;=CHEMO DRUGS^2^69
 ;;^UTILITY(U,$J,358.4,605,0)
 ;;=OTHER DRUGS^3^69
 ;;^UTILITY(U,$J,358.4,606,0)
 ;;=NEW PATIENT^2^70
 ;;^UTILITY(U,$J,358.4,607,0)
 ;;=ESTABLISHED PATIENT^1^70
 ;;^UTILITY(U,$J,358.4,608,0)
 ;;=CONSULTATIONS^3^70
 ;;^UTILITY(U,$J,358.4,609,0)
 ;;=POST OP^4^70
 ;;^UTILITY(U,$J,358.4,610,0)
 ;;=RESPIRATORY^10^71
 ;;^UTILITY(U,$J,358.4,611,0)
 ;;=CARDIOVASCULAR^4^71
 ;;^UTILITY(U,$J,358.4,612,0)
 ;;=ABDOMINAL PAIN^2^71
 ;;^UTILITY(U,$J,358.4,613,0)
 ;;=AFTERCARE POST SURGERY^3^71
 ;;^UTILITY(U,$J,358.4,614,0)
 ;;=COMMON VASCULAR DX^1^71
 ;;^UTILITY(U,$J,358.4,615,0)
 ;;=POST-OP COMPLICATIONS^9^71
 ;;^UTILITY(U,$J,358.4,616,0)
 ;;=METASTATIC CANCER SITES^8^71
 ;;^UTILITY(U,$J,358.4,617,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^5^71
 ;;^UTILITY(U,$J,358.4,618,0)
 ;;=HEMATOLOGY/ONCOLOGY^6^71
 ;;^UTILITY(U,$J,358.4,619,0)
 ;;=INFECTIOUS DISEASE^7^71
 ;;^UTILITY(U,$J,358.4,620,0)
 ;;=BIOPSY^1^72
 ;;^UTILITY(U,$J,358.4,621,0)
 ;;=CENTRAL VENOUS ACCESS PROCEDURES^2^72
 ;;^UTILITY(U,$J,358.4,622,0)
 ;;=PERIPHERAL ANGIOPLASTIES^3^72
 ;;^UTILITY(U,$J,358.4,623,0)
 ;;=PROSTHETIC ANEURYSM REPAIR^4^72
 ;;^UTILITY(U,$J,358.4,624,0)
 ;;=VASCULAR INJECTION PROCEDURES^5^72
 ;;^UTILITY(U,$J,358.4,625,0)
 ;;=BLIND REHAB SERVICE CODES^1^73
 ;;^UTILITY(U,$J,358.4,626,0)
 ;;=REFRACTION^3^73
 ;;^UTILITY(U,$J,358.4,627,0)
 ;;=GLASSES/CONTACT LENSES^4^73
 ;;^UTILITY(U,$J,358.4,628,0)
 ;;=VISUAL FIELDS^5^73
 ;;^UTILITY(U,$J,358.4,629,0)
 ;;=PHOTOGRAPHY^6^73
 ;;^UTILITY(U,$J,358.4,630,0)
 ;;=LOW VISION^7^73
 ;;^UTILITY(U,$J,358.4,631,0)
 ;;=SPECIAL PROCEDURES^8^73
 ;;^UTILITY(U,$J,358.4,632,0)
 ;;=TEAM MEETINGS/COUNSELING^10^73
 ;;^UTILITY(U,$J,358.4,633,0)
 ;;=ESTABLISHED PATIENT^1^74
 ;;^UTILITY(U,$J,358.4,634,0)
 ;;=NEW PATIENT^2^74
 ;;^UTILITY(U,$J,358.4,635,0)
 ;;=VISION DDX (CODE BY BETTER EYE)^1^75
 ;;^UTILITY(U,$J,358.4,636,0)
 ;;=DIABETES^4^75
 ;;^UTILITY(U,$J,358.4,637,0)
 ;;=GLAUCOMA^4^75
 ;;^UTILITY(U,$J,358.4,638,0)
 ;;=VF HA EOM OTHER^5^75
 ;;^UTILITY(U,$J,358.4,639,0)
 ;;=LIDS AND LASHES^6^75
 ;;^UTILITY(U,$J,358.4,640,0)
 ;;=CONJUNCTIVA, CORNEA, AND SCLERA^7^75
 ;;^UTILITY(U,$J,358.4,641,0)
 ;;=PUPILS/IRIS^8^75
 ;;^UTILITY(U,$J,358.4,642,0)
 ;;=LENS AND VITREOUS^9^75
 ;;^UTILITY(U,$J,358.4,643,0)
 ;;=MACULA AND OPTIC NERVE^10^75
 ;;^UTILITY(U,$J,358.4,644,0)
 ;;=RETINA^11^75
 ;;^UTILITY(U,$J,358.4,645,0)
 ;;=GLOBE/ORBIT^12^75
 ;;^UTILITY(U,$J,358.4,646,0)
 ;;=V CODES^13^75
 ;;^UTILITY(U,$J,358.4,647,0)
 ;;=MFH-NON CLINICIAN VISIT CODES^8^76
 ;;^UTILITY(U,$J,358.4,648,0)
 ;;=NURSING PROCEDURES^9^76
 ;;^UTILITY(U,$J,358.4,649,0)
 ;;=SPLINTS^10^76
 ;;^UTILITY(U,$J,358.4,650,0)
 ;;=MFH-CLINICIAN VISIT CODES^7^76
 ;;^UTILITY(U,$J,358.4,651,0)
 ;;=FUNCTIONAL RPTING MOBILITY^3^76
 ;;^UTILITY(U,$J,358.4,652,0)
 ;;=FUNCTIONAL RPTING BODY POSITION^1^76
 ;;^UTILITY(U,$J,358.4,653,0)
 ;;=FUNCTIONAL RPTING CARRY OBJECTS^2^76
 ;;^UTILITY(U,$J,358.4,654,0)
 ;;=FUNCTIONAL RPTING SELF CARE^7^76
 ;;^UTILITY(U,$J,358.4,655,0)
 ;;=FUNCTIONAL RPTING OTH PT/OT PRI^4^76
 ;;^UTILITY(U,$J,358.4,656,0)
 ;;=FUNCTIONAL RPTING OTH PT/OT SUB^5^76
 ;;^UTILITY(U,$J,358.4,657,0)
 ;;=CARDIOVASCULAR^2^77
 ;;^UTILITY(U,$J,358.4,658,0)
 ;;=ENDOCRINE/METABOLIC^4^77
 ;;^UTILITY(U,$J,358.4,659,0)
 ;;=PULMONARY^20^77
 ;;^UTILITY(U,$J,358.4,660,0)
 ;;=EENT^5^77
 ;;^UTILITY(U,$J,358.4,661,0)
 ;;=MUSCULOSKELETAL^10^77
 ;;^UTILITY(U,$J,358.4,662,0)
 ;;=NEURO^15^77
 ;;^UTILITY(U,$J,358.4,663,0)
 ;;=MENTAL HEALTH^13^77
 ;;^UTILITY(U,$J,358.4,664,0)
 ;;=GASTROENTEROLOGY^6^77
 ;;^UTILITY(U,$J,358.4,665,0)
 ;;=GU / RENAL^7^77
 ;;^UTILITY(U,$J,358.4,666,0)
 ;;=WOMEN'S HEALTH^28^77
 ;;^UTILITY(U,$J,358.4,667,0)
 ;;=HEMATOLOGY/ONCOLOGY^8^77
 ;;^UTILITY(U,$J,358.4,668,0)
 ;;=INFECTIOUS DISEASE^9^77
 ;;^UTILITY(U,$J,358.4,669,0)
 ;;=DERMATOLOGY^3^77
 ;;^UTILITY(U,$J,358.4,670,0)
 ;;=HISTORY OF ILLNESS^29^77
 ;;^UTILITY(U,$J,358.4,671,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^31^77
 ;;^UTILITY(U,$J,358.4,672,0)
 ;;=INJURY/TRAUMA^21^77
 ;;^UTILITY(U,$J,358.4,673,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^35^77
 ;;^UTILITY(U,$J,358.4,674,0)
 ;;=SEXUAL TRAUMA^37^77
 ;;^UTILITY(U,$J,358.4,675,0)
 ;;=PAIN^17^77
 ;;^UTILITY(U,$J,358.4,676,0)
 ;;=OTHER REASONS^38^77
 ;;^UTILITY(U,$J,358.4,677,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^39^77
 ;;^UTILITY(U,$J,358.4,678,0)
 ;;=COMMON DIAGNOSES^1^77
 ;;^UTILITY(U,$J,358.4,679,0)
 ;;=NEW PATIENT^2^78
 ;;^UTILITY(U,$J,358.4,680,0)
 ;;=ESTABLISHED PATIENT^1^78
